Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed)
ID: 350036Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $325K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed)" aimed at enhancing research education in genomics, particularly for individuals from diverse and underrepresented backgrounds in biomedical and behavioral sciences. This initiative seeks to support the development of skill-building courses and mentored research experiences for undergraduate and post-baccalaureate trainees, thereby promoting career pathways in genome sciences and related fields. The program emphasizes the importance of a diverse genomics workforce to address contemporary research challenges and includes a budget of up to $325,000 in direct costs annually, with a total award period not exceeding five years. Interested applicants must submit a letter of intent and adhere to multiple submission deadlines, with the final closing date set for January 27, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Institutes of Health (NIH) has issued a funding opportunity titled "Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed)." This program aims to enhance research education activities in genomics, with a specific focus on supporting individuals from diverse backgrounds and groups underrepresented in biomedical and behavioral sciences. The funding encourages the development of skill-building courses and mentored research experiences for undergraduate and post-baccalaureate trainees, promoting career pathways in genome sciences and related fields. Key programmatic elements include summer, semester, or academic year research opportunities and courses for skills development. Applicants must provide evidence of institutional support, a capable program director, and experienced faculty mentors. The total award period may not exceed five years, with a budget of up to $325,000 in direct costs annually. Applications will be peer-reviewed based on the significance, investigator capabilities, innovation, and overall approach to recruiting and retaining diverse participants. This initiative aligns with NIH's broader goal of fostering a diverse, well-trained research workforce capable of tackling contemporary challenges in genomics, thereby ensuring the future of biomedical research. The application process begins with a letter of intent and has multiple submission deadlines through January 2025.
    Similar Opportunities
    NHGRI Short Courses for Genomics-Related Research Education (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NHGRI Short Courses for Genomics-Related Research Education" (R25), aimed at enhancing research education in genomics. This initiative supports the development of advanced short courses focused on skills development in genome sciences, genomic medicine, and the ethical, legal, and social implications of genomics, targeting both emerging and established researchers. Funded projects may receive up to $150,000 annually for a maximum duration of five years, with applications due by January 25, 2025. Interested applicants can find more information and submit inquiries via the NIH OER Webmaster at OERWebmaster03@od.nih.gov or through the provided link to the full announcement at http://grants.nih.gov/grants/guide/pa-files/PAR-22-095.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for Transforming NHGRI�s Diversity Action Plan (R25 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Funding Opportunity Announcement (FOA) aimed at transforming the National Human Genome Research Institute's (NHGRI) Diversity Action Plan (R25 Clinical Trials Not Allowed) to enhance workforce diversity in genomics. This initiative seeks to support the training, employment, and retention of individuals from underrepresented backgrounds in the biomedical workforce, aligning with NHGRI's strategic objectives to foster diverse scientific teams that drive innovation and creativity. The FOA is expected to be published in Summer 2023, with applications due in Early 2024, and the estimated award date is set for September 9, 2024. For further inquiries, interested parties can contact Dr. Lucia A. Hindorff at hindorffl@mail.nih.gov.
    Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Heart, Lung, and Blood Institute (NHLBI), is offering a federal grant opportunity titled "Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)." This program aims to support educational activities that enhance the diversity of the biomedical, behavioral, and clinical research workforce by providing research experiences and related opportunities for individuals from underrepresented groups. The initiative is crucial for addressing health disparities in cardiovascular, pulmonary, and hematologic diseases by fostering a diverse scientific workforce. Interested applicants can apply for funding up to $175,000 per year for a maximum of five years, with applications opening on December 29, 2023, and a submission deadline of August 19, 2026. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-25-001.html.
    NICHD Research Education Programs (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) for Research Education Programs (R25), aimed at enhancing training for the biomedical, behavioral, and clinical research workforce. This grant supports innovative educational activities focused on research skills development, with a funding ceiling of $150,000 per year for a maximum of five years, and is not intended for clinical trials. The initiative emphasizes the importance of creating accessible educational opportunities that foster diversity and collaboration among participants, ranging from upper undergraduates to faculty. Interested applicants can find more information and application guidelines at the provided link, with proposals due by May 25, 2025, and inquiries directed to grantsinfo@nih.gov.
    NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIAID Research Education Program, aimed at advancing the careers of a diverse research workforce through educational activities. This program specifically targets individuals from underrepresented backgrounds in the biomedical and behavioral sciences, focusing on skills development courses, research experiences, and mentoring activities, while explicitly excluding clinical trials. With a funding opportunity number of PAR-23-282, applicants can request up to $351,000 annually for a maximum of five years, with the application period opening on December 26, 2023, and a submission deadline of May 25, 2024. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage for additional details.
    Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity" (RFA-HG-23-017), aimed at promoting health equity through innovative genomic research. This initiative encourages applicants to propose research that enhances the understanding and application of genomics across diverse U.S. populations, with a particular focus on engaging underrepresented groups and incorporating a Plan for Enhancing Diverse Perspectives (PEDP). The NIH plans to commit significant funds, with a maximum budget of $500,000 in direct costs per year for projects lasting four to five years, and applications are due by July 8, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement at NIH Grants.
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovation in the application of genomic information in clinical care, particularly for populations experiencing health disparities. The initiative seeks to enhance understanding of how to effectively implement and share genomic technologies across diverse communities, including racial and ethnic minorities, underserved rural populations, and sexual and gender minority groups. With an expected total funding of approximately $1.5 million for fiscal year 2024, individual project budgets may reach up to $250,000. Interested applicants must submit their proposals by February 11, 2025, and can find additional details and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting proposals for the "Advancing Genomic Medicine Research (R01 Clinical Trial Optional)" grant, aimed at stimulating innovative research in the implementation of genomic technologies in clinical care. This funding opportunity emphasizes addressing health disparities and requires applicants to develop a Plan for Enhancing Diverse Perspectives to ensure inclusivity in research teams and participant recruitment. The initiative seeks to explore the value of genomic data in improving clinical outcomes, identify barriers to implementation, and develop effective data-sharing methods, with approximately $2.4 million available for three awards and an additional $700,000 for one award in fiscal year 2024. Applications are due by February 12, 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)" aimed at stimulating innovation in the implementation and sharing of genomic information in clinical care across diverse populations. This initiative encourages applications for small research projects that explore the integration of genomic data into clinical practice, assess barriers to implementation, and develop innovative data analysis techniques, particularly focusing on underrepresented populations in genomic research. The maximum budget for each application is $50,000 over a two-year period, with a total funding expectation of approximately $150,000 for FY 2024. Interested applicants must submit their proposals by February 12, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovative research in the integration of genomic information into clinical care, particularly for populations experiencing health disparities. This initiative encourages proposals that address implementation science, barriers to genomic medicine, and the integration of genomic data with health and social determinants, with a focus on enhancing health equity among underrepresented groups. The grant provides funding up to $250,000, with applications open from November 1, 2023, until the close date of February 11, 2025. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.